Keratinizing-type squamous cell carcinoma of the oropharynx: P16 overexpression is associated with positive high-risk HPV status and improved survival

American Journal of Surgical Pathology

Volumn 38, Issue 6, 2014, Pages 809-815

  Cai, Chunyu ^a   Chernock, Rebecca D ^a   Pittman, Meredith E ^a   El Mofty, Samir K ^a   Thorstad, Wade L ^a   Lewis, James S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Human papillomavirus; Keratinizing squamous cell carcinoma; Oropharynx; p16; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; ONCOPROTEIN; TUMOR MARKER; VIRUS RNA;

ADULT; AGED; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PHENOTYPE; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME; UPREGULATION; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84900837528     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000183     Document Type: Article

References (33)

1. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29:4294-4301
2. Joseph AW, D'Souza G. Epidemiology of human papillomavirusrelated head and neck cancer. Otolaryngol Clin North Am. 2012;45:739-764
3. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35
4. Fischer CA, Zlobec I, Green E, et al. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?. Int J Cancer. 2010;126:1256-1262
5. Rich JT, Milov S, Lewis JS Jr, et al. Transoral laser microsurgery (Tlm) +/- Adjuvant therapy for advanced stage oropharyngeal cancer: Outcomes and prognostic factors. Laryngoscope. 2009;119: 1709-1719
6. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269
7. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: A distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463-1470
8. Chernock RD, El-Mofty SK, Thorstad WL, et al. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: Utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3:186-194
9. Lewis JS Jr, Khan RA, Masand RP, et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma-A prospective cohort and interobserver variability study. Histopathology. 2012;60:427-436
10. El-Mofty SK, Zhang MQ, Davila RM. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: A reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol. 2008;2: 163-168
11. Mehrad M, Carpenter DH, Chernock RD, et al. Papillary squamous cell carcinoma of the head and neck: Clinicopathologic and molecular features with special reference to human papillomavirus. Am J Surg Pathol. 2013;37:1349-1356
12. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: Frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720-1724
13. Chernock RD, Lewis JS Jr, Zhang Q, et al. Human papillomaviruspositive basaloid squamous cell carcinomas of the upper aerodigestive tract: A distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol. 2010;41:1016-1023
14. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044-1050
15. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: Relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5:108-116
16. Singhi AD, Stelow EB, Mills SE, et al. Lymphoepithelial-like carcinoma of the oropharynx: A morphologic variant of HPVrelated head and neck carcinoma. Am J Surg Pathol. 2010;34: 800-805
17. Johnson N, Francheschi S, Ferlay J, et al. Squamous cell carcinoma of the oral cavity and oropharynx. In: Barnes EL, et al, ed. World Health Organization Classification of Tumours-Pathology and Genetics Head and Neck Tumours. Lyon, France: IARC Press; 2005:168-175
18. Chen ZW, Weinreb I, Kamel-Reid S, et al. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: Staining patterns are suggestive of HPV status. Head Neck Pathol. 2012;6:422-429
19. Lewis JS Jr, Chernock RD, Ma XJ, et al. Partial p16 staining in oropharyngeal squamous cell carcinoma: Extent and pattern correlate with human papillomavirus RNA status. Mod Pathol. 2012;25:1212-1220
20. Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US Cooperative Group Trials. Am J Surg Pathol. 2012;36:945-954
21. Lewis JS Jr, Thorstad WL, Chernock RD, et al. P16 positive oropharyngeal squamous cell carcinoma: An entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34:1088-1096
22. Ukpo OC, Flanagan JJ, Ma XJ, et al. High risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35:1343-1350
23. Schache AG, Liloglou T, Risk JM, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: Sensitivity, specificity, and prognostic discrimination. Clin Cancer Res. 2011;17:6262-6271
24. Brugere J, Guenel P, Leclerc A, et al. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer. 1986;57:391-395
25. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:712-717
26. Poeta ML, Manola J, Goldwasser MA, et al. Tp53 mutations and survival in squamous-cell carcinoma of the head and neck. N Engl J Med. 2007;357:2552-2561
27. Chernock RD, Wang X, Gao G, et al. Detection and significance of human papillomavirus, Cdkn2a(P16) and Cdkn1a(P21) expression in squamous cell carcinoma of the larynx. Mod Pathol. 2012;26: 223-231
28. Lingen MW, Xiao W, Schmitt A, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013;49:1-8
29. Haughey BH, Sinha P. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope. 2013;122(suppl 2):S13-S33
30. Carpenter DH, El-Mofty SK, Lewis JS Jr. Undifferentiated carcinoma of the oropharynx: A human papillomavirus-Associated tumor with a favorable prognosis. Mod Pathol. 2011;24:1306-1312
31. El-Naggar AK, Westra WH. P16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: A guide for interpretative relevance and consistency. Head Neck. 2012;34:459-461
32. Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011;35:1679-1684
33. Kraft S, Faquin WC, Krane JF. HPV-Associated neuroendocrine carcinoma of the oropharynx: A rare new entity with potentially aggressive clinical behavior. Am J Surg Pathol. 2012;36:321-330.